Abstract: Described herein are compositions comprising, a polymer, a non-physiological solution; and a visualization agent; wherein the polymer is soluble in the non-physiological solution and insoluble at physiological conditions. Methods of preparing the compositions are disclosed as well as methods of using these compositions to treat vascular conditions.

Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).

Abstract: Embodiments herein include a connector coupling arranged to mate and/or unmate first and second connectors. The connector coupling includes a first collar having one or more locking members, a second collar arranged to receive the first collar, the second collar being rotatable relative to the first collar, and a locking mechanism. The connector coupling is moveable in a mating direction to mate the first and second connectors and an unmating direction to unmate the connectors. The locking mechanism is disengaged when the connector coupling is moved in a mating direction. For example, the locking mechanism may be moveable from a first engaged position to a first disengaged position when the connector coupling is moved in the mating direction. As another example, the locking mechanism may remain disengaged until the connectors are fully mated.

Abstract: Described herein are durable coatings, i.e. for medical devices, and methods of forming the coatings.

Abstract: Described herein are compositions comprising, a polymer; a non-physiological solution; and a visualization agent; wherein the polymer is soluble in the non-physiological solution and insoluble at physiological conditions. Methods of preparing the compositions are disclosed as well as methods of using these compositions to treat vascular conditions.

Abstract: Described herein are durable coatings, i.e. for medical devices, and methods of forming the coatings.

Abstract: Described herein are polymers and associated methods to occlude structures and malformations of the vasculature with polymers with delayed controlled rates of expansion. Methods of forming such devices are also disclosed.

Abstract: Technology is disclosed herein for orbit raising of multiple spacecraft launched with a single launch vehicle. Two or more spacecraft are configured in a stacked launch configuration in which a lower spacecraft is mechanically coupled with a payload adapter of a launch vehicle with one or more upper spacecraft above the lower spacecraft. Propellant that is stored in the lower spacecraft during launch is transferred to an upper spacecraft in the stack after launch. The propellent may be used by the upper spacecraft for an orbit raising maneuver that raises the orbit of at least the upper spacecraft from a first orbit to a second orbit. Storing the propellant in the lower spacecraft lowers the center of mass of the stack during launch. Lowering the center of mass reduces the structural bending moment of the stack during launch, which allows a greater total launch mass.

Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).

Abstract: Provided herein are coated substrates. Also provided herein are methods for attaching phosphonates, phosphonic acids, or derivatives thereof to an organic or an inorganic substrate (e.g., a metal oxide substrate) via phosphonate chemistry to form the coated substrates provided herein.

Abstract: Described herein are polymers and associated methods to occlude structures and malformations of the vasculature with polymers with delayed controlled rates of expansion. Methods of forming such devices are also disclosed.

Abstract: Provided herein are coated substrates. Also provided herein are methods for attaching phosphonates, phosphonic acids, or derivatives thereof to an organic or an inorganic substrate (e.g., a metal oxide substrate) via phosphonate chemistry to form the coated substrates provided herein.

Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).

Abstract: Described herein are polymers and associated methods to occlude structures and malformations of the vasculature with polymers with delayed controlled rates of expansion. Methods of forming such devices are also disclosed.

Abstract: Described herein are substrate coatings.

Abstract: Embodiments herein include a connector coupling arranged to mate and/or unmate first and second connectors. The connector coupling includes a first collar having one or more locking members, a second collar arranged to receive the first collar, the second collar being rotatable relative to the first collar, and a locking mechanism. The connector coupling is moveable in a mating direction to mate the first and second connectors and an unmating direction to unmate the connectors. The locking mechanism is disengaged when the connector coupling is moved in a mating direction. For example, the locking mechanism may be moveable from a first engaged position to a first disengaged position when the connector coupling is moved in the mating direction. As another example, the locking mechanism may remain disengaged until the connectors are fully mated.

Abstract: Described herein are durable coatings, i.e. for medical devices, and methods of forming the coatings.

Abstract: Described herein are polymers and associated methods to occlude structures and malformations of the vasculature with polymers with delayed controlled rates of expansion. Methods of forming such devices are also disclosed.

Abstract: Described herein are compositions comprising, a polymer; a non-physiological solution; and a visualization agent; wherein the polymer is soluble in the non-physiological solution and insoluble at physiological conditions. Methods of preparing the compositions are disclosed as well as methods of using these compositions to treat vascular conditions.

Abstract: A spacecraft includes a propulsion system including an inert gas stored in a set of pressurant tanks, one or more electric thrusters operable with the inert gas, one or more cold gas thrusters operable with the inert gas; and a pneumatic arrangement including commandable valves.